Tikun Olam Cannbit Pharmaceuticals
Pharmaceuticals, 135 Duryea Rd, Ziporit Business Park, New York, 11747, United States, 51-200 Employees
Phone Number: +17*********
Who is TIKUN OLAM CANNBIT PHARMACEUTICALS
Cannbit pharmaceuticals is a public company, acquired Israeli medical cannabis pioneer, Tikun Olam in 2019. Tikun Olam-Cannbit LTD. is a leading supplier on the local market. Since its es...
Read More
-
Headquarters: 135 Duryea Rd, Ziporit Business Park, New York, 11747, United States
-
Date Founded: 2005
-
Employees: 51-200
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2833
|
NAICS Code: 325411 |
Show More
Does something look wrong? Fix it. | View contact records from TIKUN OLAM CANNBIT PHARMACEUTICALS
Tikun Olam Cannbit Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Tikun Olam Cannbit Pharmaceuticals
Answer: Tikun Olam Cannbit Pharmaceuticals's headquarters are located at 135 Duryea Rd, Ziporit Business Park, New York, 11747, United States
Answer: Tikun Olam Cannbit Pharmaceuticals's phone number is +17*********
Answer: Tikun Olam Cannbit Pharmaceuticals's official website is https://tikunolam.com
Answer: Tikun Olam Cannbit Pharmaceuticals's revenue is $1 Billion and Over
Answer: Tikun Olam Cannbit Pharmaceuticals's SIC: 2833
Answer: Tikun Olam Cannbit Pharmaceuticals's NAICS: 325411
Answer: Tikun Olam Cannbit Pharmaceuticals has 51-200 employees
Answer: Tikun Olam Cannbit Pharmaceuticals is in Pharmaceuticals
Answer: Tikun Olam Cannbit Pharmaceuticals contact info: Phone number: +17********* Website: https://tikunolam.com
Answer: Cannbit pharmaceuticals is a public company, acquired Israeli medical cannabis pioneer, Tikun Olam in 2019. Tikun Olam-Cannbit LTD. is a leading supplier on the local market. Since its establishment, the company has treated more than 30,000 patients in Israel. From childhood through to old age, patients with a variety of medical conditions have received treatment from the companys experience worldwide in the treatment of patients and have alleviated their suffering through medical cannabis. Cannbit pharmaceuticals operates throughout the entire value chain while maintaining an ecosystem that integrates values of sustainability, therapeutic continuity, and uniformity in the quality of its products. Cannbit has production facility in the north of Israel and cultivation farm at the Dead Sea were received the EU-GMP certification. Patients are at the core of the our hearts, minds, planning and action, and a unique system of care has been built for years around them. Thanks to our long-years experience and pharmaceutical approach, Cannbit is endorsed by the leading health insurers, medical institutes of Israel, and by healthcare professional. We formed a one of a kind ecosystem which includes research and clinical trials, genetic R&D for development of unique strains tailor-made for real medical needs, cultivation and propagation farms, a production facility, an advanced laboratory and technological R&D site, a logistics center, a dispensary and direct delivery to the customers home, as well as a service and pharma system that includes patient training and counselling, via our caring qualified nurses while maintaining a personalized treatment sequence.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month